13,14-dihydroprostaglandin e1 has been researched along with dinoprostone in 2 studies
Studies (13,14-dihydroprostaglandin e1) | Trials (13,14-dihydroprostaglandin e1) | Recent Studies (post-2010) (13,14-dihydroprostaglandin e1) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
27 | 2 | 3 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | 13,14-dihydroprostaglandin e1 (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, TL; Sharif, NA | 1 |
Hesse, WH; Peskar, BA; Rudofsky, G | 1 |
2 other study(ies) available for 13,14-dihydroprostaglandin e1 and dinoprostone
Article | Year |
---|---|
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Topics: Binding, Competitive; Cell Line; Cell Membrane; Dinoprostone; DNA, Recombinant; Dose-Response Relationship, Drug; Humans; Ligands; Prostaglandins; Radioligand Assay; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Tritium | 2000 |
[Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arterial Occlusive Diseases; Biotransformation; Dinoprostone; Female; Humans; Infusions, Intravenous; Male; Middle Aged | 1991 |